Social determinants of health are potentially modifiable risk factors that can negatively affect outcomes for pediatric liver transplant recipients.
Different pediatric transplant centers may face different challenges regarding identifying high risk patients and connecting them with the appropriate resources. This webinar aims to inform the transplant community about the known impact of social determinants of health on pediatric liver transplant outcomes, discuss practical and efficient screening tools to identify liver transplant recipients at-risk for non-optimal outcomes and connect them with the appropriate resources. The webinar also discusses barriers in implementation and opportunities for improvement.
Dr. Ibrahim is a physician scientist, she studies the mechanism of liver injury and inflammation in nonalcoholic steatohepatitis. She is the director of the Pilot and Feasibility program at the Digestive Disease Center at Mayo Clinic, the pediatric associate editor for “HEPATOLOGY” and a steering committee member of the AASLD pediatric special interest group. She is a NASPGHAN fellow, and a member of the SPLIT education and advocacy committees. Dr. Ibrahim is the Medical Director of the Pediatric Liver Transplant Program at Mayo clinic and is interested in developing models that better predict the acuity of the pediatric liver transplant candidate on the wait list.
Jessica Hochberg is a pediatric hepatologist and Assistant Professor of Pediatrics at the Miami Transplant Institute at Jackson Memorial Hospital/University of Miami Miller School of Medicine in Miami, FL. Dr. Hochberg’s interests surround pediatric liver disease and disparities in care that may affect waitlist outcomes (both pre and post-transplant morbidity and mortality) and organ allocation (including barriers to care, racial/ethnic disparities, differences in social determinants of health, etc). She is also interested in autoimmune and cholestatic liver diseases and is a co-investigator in the Pediatric Primary Sclerosing Cholangitis Consortium, currently working on publishing data related to race and ethnicity in PSC.
Noelle Ebel is an Associate Clinical Professor at Stanford University where she is the Director of the Alagille Syndrome Program. Her career goal is to improve the health and lives of children with liver disease, particularly for children with complex heart-liver disease, and to continue to address health disparities in pediatric liver transplantation. Her clinical and research interests lie at the intersection of the heart and the liver, specifically Fontan associated liver disease, indications for combined heart-liver transplantation and care for children with Alagille syndrome with specific attention to patients with liver disease requiring complex heart surgeries. She remains committed to addressing health disparities in pediatric liver transplantation and is the Director of Policy in the Office of Child Health Equity at Stanford.
Sharad Wadhwani is a pediatric hepatologist and Assistant Professor of Pediatrics at the University of California, San Francisco. Dr. Wadhwani’s research interests are at the intersection of pediatric hepatology, population health, and health systems improvement. His work has been funded by the American Association for the Study of Liver Disease, the Starzl Network for Excellence in Pediatric Transplantation, and the NIH. He is the principal investigator of the NIH-funded, multi-center SOCIAL-Tx study that seeks to better understand how the social determinants of health, that is-where we live, learn, work, and play, impact outcomes for children undergoing liver transplant and how we can use such knowledge to improve outcomes after transplant. Further, Dr. Wadhwani is leading the initiative to implement routine social risk screening across transplant centers in the Starzl Network for Excellence in Transplantation. Father to two young children, in his spare time Dr. Wadhwani is usually playing outdoors, cooking, or listening to the “Sing 2” soundtrack—again.